France
· Delayed Price · Currency is EUR Valbiotis Statistics
Total Valuation
Valbiotis has a market cap or net worth of EUR 21.28 million. The enterprise value is 8.84 million.
| Market Cap | 21.28M |
| Enterprise Value | 8.84M |
Important Dates
The next estimated earnings date is Friday, December 27, 2024.
| Earnings Date | Dec 27, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Valbiotis has 15.76 million shares outstanding. The number of shares has increased by 23.46% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 15.76M |
| Shares Change (YoY) | +23.46% |
| Shares Change (QoQ) | +26.37% |
| Owned by Insiders (%) | 4.18% |
| Owned by Institutions (%) | 8.50% |
| Float | 15.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 36.24 |
| PB Ratio | 1.26 |
| P/TBV Ratio | 1.35 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.99 |
| EV / Sales | 16.77 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -1.19 |
Financial Position
The company has a current ratio of 4.89, with a Debt / Equity ratio of 0.36.
| Current Ratio | 4.89 |
| Quick Ratio | 4.46 |
| Debt / Equity | 0.36 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.82 |
| Interest Coverage | -91.60 |
Financial Efficiency
Return on equity (ROE) is -62.73% and return on invested capital (ROIC) is -27.41%.
| Return on Equity (ROE) | -62.73% |
| Return on Assets (ROA) | -22.31% |
| Return on Capital (ROIC) | -27.41% |
| Revenue Per Employee | 10,135 |
| Profits Per Employee | -172,000 |
| Employee Count | 52 |
| Asset Turnover | 0.02 |
| Inventory Turnover | 2.35 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -69.89% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -69.89% |
| 50-Day Moving Average | 1.29 |
| 200-Day Moving Average | 2.11 |
| Relative Strength Index (RSI) | 53.17 |
| Average Volume (20 Days) | 102,871 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Valbiotis had revenue of EUR 527,000 and -8.94 million in losses. Loss per share was -0.63.
| Revenue | 527,000 |
| Gross Profit | -2.48M |
| Operating Income | -9.07M |
| Pretax Income | -8.95M |
| Net Income | -8.94M |
| EBITDA | -9.21M |
| EBIT | -9.07M |
| Loss Per Share | -0.63 |
Balance Sheet
The company has 18.55 million in cash and 6.10 million in debt, giving a net cash position of 12.44 million or 0.79 per share.
| Cash & Cash Equivalents | 18.55M |
| Total Debt | 6.10M |
| Net Cash | 12.44M |
| Net Cash Per Share | 0.79 |
| Equity (Book Value) | 16.84M |
| Book Value Per Share | 1.07 |
| Working Capital | 18.68M |
Cash Flow
In the last 12 months, operating cash flow was -7.41 million and capital expenditures -30,000, giving a free cash flow of -7.44 million.
| Operating Cash Flow | -7.41M |
| Capital Expenditures | -30,000 |
| Free Cash Flow | -7.44M |
| FCF Per Share | -0.47 |
Margins
| Gross Margin | n/a |
| Operating Margin | -1,720.68% |
| Pretax Margin | -1,698.48% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Valbiotis does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -23.46% |
| Shareholder Yield | -23.46% |
| Earnings Yield | -46.83% |
| FCF Yield | -34.98% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Valbiotis has an Altman Z-Score of 3.52.
| Altman Z-Score | 3.52 |
| Piotroski F-Score | n/a |